Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis

Molecular Carcinogenesis

Volumn 46, Issue 12, 2007, Pages 949-957

  Lee, Sangjun ^a,c   Chari, Nikhil S ^a,c   Hyung, Woo Kim ^a   Wang, Xuemei ^a   Roop, Dennis R ^b   Cho, Song H ^a,c   DiGiovanni, John ^a   McDonnell, Timothy J ^a,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Keratinocyte tumorigenesis; Nonmelanoma skin cancer; Oncogenes; Proliferation

Indexed keywords

PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENOTYPE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MOUSE; NEWBORN; NONHUMAN; ONCOGENE H RAS; PAPILLOMA; PHENOTYPE; PRIORITY JOURNAL; SKIN CARCINOGENESIS; TRANSGENE; TRANSGENIC MOUSE; TUMOR VOLUME; ULTRAVIOLET IRRADIATION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; EPIDERMIS; FEMALE; GENES, RAS; KERATINOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, TRANSGENIC; PAPILLOMA; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

MUS; MUS MUSCULUS;

EID: 36849078073     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20334     Document Type: Article

References (46)

1. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: Incidence. J Am Acad Dermatol 1994;30:774-778.
2. Spurgers KB, Chari NS, Bohnenstiehl NL, McDonnell TJ. Molecular mediators of cell death in multistep carcinogenesis: A path to targeted therapy. Cell Death Differ 2006;13:1360-1370.
3. Rodriguez-Villanueva J, Colome MI, Brisbay S, McDonnell TJ. The expression and localization of bcl-2 protein in normal skin and in non-melanoma skin cancers. Pathol Res Pract 1995;191:391-398.
4. Delehedde M, Cho SH, Sarkiss M, et al. Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer. Cancer 1999;85:1514-1522.
5. Delehedde M, Cho SH, Hamm R, et al. Impact of Bcl-2 and Ha-ras on keratinocytes in organotypic culture. J Invest Dermatol 2001;116:366-373.
6. McDonnell TJ. Cell division versus cell death: A functional model of multistep neoplasia. Mol Carcinog 1993;8:209-213.
7. Nakagawa K, Yamamura K, Maeda S, Ichihashi M. bcl-2 expression in epidermal keratinocytic diseases. Cancer 1994;74:1720-1724.
8. Bigelow RL, Chari NS, Unden AB, et al. Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1. J Biol Chem 2004; 279:1197-1205.
9. Rodriguez-Villanueva J, Greenhalgh D, Wang XJ, et al. Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation. Oncogene 1998;16:853-863.
10. Haas K, Johannes C, Geisen C, et al. Malignant transformation by cyclin E and Ha-Ras correlates with lower sensitivity towards induction of cell death but requires functional Myc and C DK4. Oncogene 1997;15:2615-2623.
11. Chin L, Tam A, Pomerantz J, et al. Essential role for oncogenic Ras in tumour maintenance. Nature 1999;400:468-472.
12. Reuter CW, Morgan MA, Bergmann L. Targeting the Ras signaling pathway: A rational, mechanism-based treatment for hematologic malignancies? Blood 2000;96:1655-1669.
13. Reifenberger J, Knobbe CB, Sterzinger AA, et al. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas. Int J Cancer 2004;109:377-384.
14. Kusakari T, Kariya M, Mandai M, et al. C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro. Br J Cancer 2003;89:2293-2298.
15. Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ. Increasing complexity of Ras signaling. Oncogene 1998;17:1395-1413.
16. Perez-Sala D, Rebollo A. Novel aspects of Ras proteins biology: Regulation and implications. Cell Death Differ 1999;6:722-728.
17. Crespo P, Leon J. Ras proteins in the control of the cell cycle and cell differentiation. Cell Mol Life Sci 2000;57:1613-1636.
18. Kimmelman AC, Nunez Rodriguez N, Chan AM. R-Ras3/M-Ras induces neuronal differentiation of PC12 cells through cell-type-specific activation of the mitogen-activated protein kinase cascade. Mol Cell Biol 2002;22:5946-5961.
19. Boukamp P. Non-melanoma skin cancer: What drives tumor development and progression? Carcinogenesis 2005;26:1657-1667.
20. Greenhalgh DA, Wang XJ, Roop DR. Multistage skin carcinogenesis in transgenic mice. Proc Assoc Am Physicians 1995;107:258-275.
21. Rossiter H, Beissert S, Mayer C, et al. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet-and chemical-induced tumorigenesis. Cancer Res 2001;61:3619-3626.
22. Dajee M, Tarutani M, Deng H, Cai T, Khavari PA. Epidermal Ras blockade demonstrates spatially localized Ras promotion of proliferation and inhibition of differentiation. Oncogene 2002;21:1527-1538.
23. Greenhalgh DA, Rothnagel JA, Quintanilla MI, et al. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene. Mol Carcinog 1993;7:99-110.
24. Venables WN, Ripley BD. Modern applied statistics with S-Plus. 3rd edition. New York: Springer; 1999.
25. Field JK, Spandidos DA. The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review). Anticancer Res 1990;10:1-22.
26. Bos JL. ras oncogenes in human cancer: A review. Cancer Res 1989;49:4682-4689.
27. McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 1991;349:254-256.
28. Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC, Fornace AJ, Jr. An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res 2000;60:6101-6110.
29. Greenhalgh DA, Wang XJ, Roop DR. Multistage skin carcinogenesis in transgenic mice. Proc Assoc Am Physicians 1995;107:258-275.
30. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS, Jr., Mayo MW. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 2000;20:1626-1638.
31. Sakata K, Kato S, Fox JC, Shigemori M, Morimatsu M. Autocrine signaling through Ras regulates cell survival activity in human glioma cells: Potential cross-talk between Ras and the phosphatidylinositol 3-kinase-Akt pathway. J Neuropathol Exp Neurol 2002;61:975-983.
32. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996;274:782-784.
33. Liptay S, Weber CK, Ludwig L, Wagner M, Adler G, Schmid RM. Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer. Int J Cancer 2003;105:735-746.
34. Liou JS, Chen JS, Faller DV. Characterization of p21Ras-mediated apoptosis induced by protein kinase C inhibition and application to human tumor cell lines. J Cell Physiol 2004;198:277-294.
35. Vos MD, Martinez A, Ellis CA, Vallecorsa T, Clark GJ. The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung. J Biol Chem 2003;278:21938-21943.
36. Cheng G, Lewis AE, Meinkoth JL. Ras stimulates aberrant cell cycle progression and apoptosis in rat thyroid cells. Mol Endocrinol 2003;17:450-459.
37. Chen CY, Faller DV. Direction of p21ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2. Oncogene 1995;11:1487-1498.
38. Gulbins E, Bissonnette R, Mahboubi A, et al. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 1995;2:341-351.
39. Tanaka Y, Nakayamada S, Fujimoto H, et al. H-Ras/mitogen-activated protein kinase pathway inhibits integrin-mediated adhesion and induces apoptosis in osteoblasts. J Biol Chem 2002;277:21446-21452.
40. Reed JC, Haldar S, Croce CM, Cuddy MP. Complementation by BCL2 and C-HA-RAS oncogenes in malignant transformation of rat embryo fibroblasts. Mol Cell Biol 1990;10:4370-4374.
41. Wang HG, Millan JA, Cox AD, et al. R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl- 2 suppressible mechanism. J Cell Biol 1995;129:1103-1114.
42. Chen CY, Faller DV. Phosphorylation of Bcl-2 protein and association with p21Ras in Ras-induced apoptosis. J Biol Chem 1996;271:2376-2379.
43. Fernandez A, Udagawa T, Schwesinger C, et al. Angiogenic potential of prostate carcinoma cells overexpressing bcl-2. J Natl Cancer Inst 2001;93:208-213.
44. Pena JC, Rudin CM, Thompson CB. A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas. Cancer Res 1998;58:2111-2116.
45. Cho SH, Delehedde M, Rodriguez-Villanueva J, Brisbay S, McDonnell TJ. Bax gene disruption alters the epidermal response to ultraviolet irradiation and in vivo induced skin carcinogenesis. Int J Mol Med 2001;7:235-241.
46. Cho S, O'Connor SL, McDonnell TJ. Evidence that nucleotide excision repair is attenuated in bax-deficient mammalian cells following ultraviolet irradiation. Exp Cell Res 2002;278:158-165.